CELC
Price
$39.91
Change
+$0.74 (+1.89%)
Updated
Aug 1 closing price
Capitalization
1.62B
5 days until earnings call
SLXN
Price
$9.28
Change
-$5.66 (-37.88%)
Updated
Aug 1 closing price
Capitalization
5.38M
Interact to see
Advertisement

CELC vs SLXN

Header iconCELC vs SLXN Comparison
Open Charts CELC vs SLXNBanner chart's image
Celcuity
Price$39.91
Change+$0.74 (+1.89%)
Volume$1.56M
Capitalization1.62B
Silexion Therapeutics
Price$9.28
Change-$5.66 (-37.88%)
Volume$360.35K
Capitalization5.38M
CELC vs SLXN Comparison Chart in %
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. SLXN commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Buy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (CELC: $39.22 vs. SLXN: $14.76)
Brand notoriety: CELC and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 145% vs. SLXN: 2085%
Market capitalization -- CELC: $1.62B vs. SLXN: $5.38M
CELC [@Biotechnology] is valued at $1.62B. SLXN’s [@Biotechnology] market capitalization is $5.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 6 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 4 bearish.
  • SLXN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than CELC.

Price Growth

CELC (@Biotechnology) experienced а +179.15% price change this week, while SLXN (@Biotechnology) price change was +1574.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

CELC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($1.63B) has a higher market cap than SLXN($5.38M). CELC YTD gains are higher at: 204.889 vs. SLXN (-69.221). SLXN has higher annual earnings (EBITDA): -16.96M vs. CELC (-114.96M). SLXN has less debt than CELC: SLXN (3.48M) vs CELC (98.7M). CELC (0) and SLXN (0) have equivalent revenues.
CELCSLXNCELC / SLXN
Capitalization1.63B5.38M30,216%
EBITDA-114.96M-16.96M678%
Gain YTD204.889-69.221-296%
P/E RatioN/AN/A-
Revenue00-
Total Cash206MN/A-
Total Debt98.7M3.48M2,835%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
34
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
6%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
25%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
29%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 5 days ago
51%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGEIX24.78N/A
N/A
Nationwide Global Sust Eq R6
PGKZX29.33N/A
N/A
PGIM Jennison Technology Z
JVAIX38.63N/A
N/A
JPMorgan Value Advantage L
ESEIX34.37N/A
N/A
Eaton Vance Atlanta Capital Sel Eq I
RDWFX12.23-0.16
-1.29%
American Funds Dvlpg Wld Gr&Inc R5

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+1.90%
IMA - CELC
87%
Closely correlated
-3.46%
MRSN - CELC
62%
Loosely correlated
-3.65%
SLXN - CELC
50%
Loosely correlated
-37.88%
ABOS - CELC
44%
Loosely correlated
-3.57%
BEAM - CELC
44%
Loosely correlated
-4.46%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-37.88%
IMA - SLXN
59%
Loosely correlated
-3.46%
CELC - SLXN
50%
Loosely correlated
+1.90%
MRSN - SLXN
43%
Loosely correlated
-3.65%
QSI - SLXN
25%
Poorly correlated
-1.35%
CHRS - SLXN
25%
Poorly correlated
-6.64%
More